[1] Takeuchi M, Urano M, Hara M,et al. Characteristic MRI findings of sarcomatoid renal cell carcinoma dedifferentiated from clear cell renal carcinoma: radiological-pathological correlation[J].Clin Imaging,2013,37(5):908-912. [2] 刘玉刚,刘鹏.肾细胞癌保留单位肾肿瘤切除与根治性手术临床疗效比较[J].医学临床研究,2016,33(8):1519-1522. [3] Kim C, Choi HJ, Cho KS. Diagnostic value of multidetector computed tomography for renal sinus fat invasion in renal cell carcinoma patients[J].Eur J Radiol,2014,83(6):914-918. [4] 张进,王共先,郭剑明,等.肾细胞癌随访5年生存分析及预后相关因素的多中心研究[J].中华泌尿外科杂志,2015,36(2):113-117. [5] Rosenkrantz AB, Matza BW, Portnoy E, et al. Impact of size of region-of-interest on differentiation of renal cell carcinoma and renal cysts on multi-phase CT: preliminary findings[J].Eur J Radiol,2014,83(2):239-244. [6] 张建军,刘高,蔡维奇,等.经腹腔镜冷循环射频消融治疗肾细胞癌12例体会[J].医学临床研究,2015,32(7):1422-1423. [7] Kim IC, Bang G, Lee JH, et al. Low C24-OH and C22-OH sulfatides in human renal cell carcinoma[J].J Mass Spectrom,2014,49(5):409-416. [8] 高明珠,王进有,张海梁,等.乳头状肾癌的临床病理特征及其预后因素[J].中国癌症杂志,2014,24(4):299-303. [9] 董樑,黄吉炜,奚倩雯,等.乳头状肾细胞癌的临床病理特征和预后分析[J].中华泌尿外科杂志,2015,36(3):183-187. [10] Steffens S, Junker K, Roos FC, et al. Small renal cell carcinomas--how dangerous are they really? Results of a large multicenter study[J].Eur J Cancer,2014,50(4):739-745. [11] 彭鼎,李学松,张崔建,等.T3 N0 M0期肾细胞癌患者预后相关因素分析:单中心182例患者回顾性研究[J].北京大学学报(医学版),2016,48(5):806-811. [12] Kroeger N, Xie W, Lee JL, et al. Metastatic non-clear cell renal cell carcinoma treated with targeted therapy agents: characterization of survival outcome and application of the International mRCC Database Consortium criteria[J].Cancer,2013,119(16):2999-3006. (本文编辑:张兴珍) [收稿日期] 2016-12-26
2017, Vol. 34 
